News

Perricone MD Unveils Advanced Neuropeptide Serums for Aging Skin

Perricone MD Unveils Advanced Neuropeptide Serums for Aging Skin

Perricone MD Reintroduces the Neuropeptide Collection

Perricone MD today proudly announces the relaunch of its esteemed Neuropeptide Collection, ushering in a new realm of intelligent skincare designed to combat noticeable signs of aging. With almost three decades of unwavering research and holistic philosophies blending beauty from both the inside and outside, this refreshing collection showcases advanced formulas aimed at nurturing skin affected by time and expression.

Harnessing the Power of Neuropeptides

Central to this innovative collection is Perricone MD's profound understanding of neuropeptide science, a path pioneered by the founder Dr. Nicholas Perricone. He was among the first to integrate neuropeptides in topical skincare, emphasizing their remarkable benefits. These potent, protein-like components work to connect surface cells, significantly diminishing wrinkle depth. Infused with the brand's cutting-edge neuropeptide technology and next-gen biotech ingredients, including biomimetic growth factor peptides, the Neuropeptide Collection enhances elasticity, lift, and contour on areas typically associated with sagging.

Neuropeptide Deep Crease Serum

The Neuropeptide Deep Crease Serum focuses on high-movement areas susceptible to intense fold marks, such as frown lines, smile lines, nasolabial folds, and creases around the eyes and forehead. This serum is meticulously formulated to smooth deep-set wrinkles and enhance surface uniformity, while reinforcing the overall appearance of skin density and structural resilience. The inclusion of plant stem cells, harvested from a rare Swiss apple, synergistically work with biotech peptides to promote thickness and support a smoother, more resilient complexion.

Neuropeptide Eyelid Lift Serum

Meanwhile, the Neuropeptide Eyelid Lift Serum offers an ultra-lightweight and fast-absorbing solution tailored specifically for the delicate upper eyelid area. This specialized serum effectively smooths out eyelid creases and uneven textures, while diminishing the appearance of drooping or sagging eyelids. Over time, the eye area receives a lifted, more defined, and vibrant look. Beyond the primary peptide technology, it also incorporates Perricone MD's groundbreaking Acyl-Glutathione, which replenishes fragile skin and helps showcase a younger, smoother appearance.

Expert Testimonials on the Relaunch

"The revamped Neuropeptide Collection encapsulates the essence of what Perricone MD stands for: skincare driven by expertise, science, and impactful results," said Lance Patterson, the Global President of Perricone MD. "With decades of dedicated research propelling our neuropeptide technology, this relaunch signifies a fresh chapter for intelligent skincare that evolves with your skin. Each formulation is designed to lift, smooth, and define, precisely addressing the needs of mature skin, all with respect and proven efficacy."

Availability of the Neuropeptide Collection

The Neuropeptide Deep Crease Serum (1 US fl. oz. / $189) and the Neuropeptide Eyelid Lift Serum (0.5 US fl. oz. / $129) are now accessible through PerriconeMD.com as well as selected retail partners. Both products are crafted for suitability across all skin types, ensuring everyone can benefit from these advanced formulas.

About Perricone MD

For nearly 30 years, Perricone MD has championed a holistic skincare and wellness system encompassing diet, dietary supplements, and potent topical skincare solutions derived from extensive clinical and consumer research. The brand was established by Dr. Nicholas Perricone, a celebrated author recognized for his guiding book, The Wrinkle Cure. Dr. Perricone's legendary work redefined skincare paradigms and highlighted the benefits of maintaining a healthy lifestyle.

Perricone MD is rooted in an unwavering pursuit of innovative excellence, driven by a fierce commitment to achieve grand results. The conviction that merely being good enough is not sufficient continually motivates our efforts to uncover the potent science behind radiant skin from both inside and outside.

Frequently Asked Questions

What is the Neuropeptide Collection by Perricone MD?

The Neuropeptide Collection is a relaunch of advanced skincare products focused on lifting and reducing wrinkles, utilizing neuropeptide technology.

Who is the founder of Perricone MD?

Dr. Nicholas Perricone, an acclaimed author and skincare expert, founded Perricone MD to revolutionize skincare approaches with scientific insights.

Are the Neuropeptide serums suitable for all skin types?

Yes, both the Neuropeptide Deep Crease Serum and the Eyelid Lift Serum are formulated to be suitable for all skin types.

Where can I purchase the Neuropeptide products?

The Neuropeptide products are available on PerriconeMD.com and at select retail partners.

What are the key ingredients in the Neuropeptide serums?

The key ingredients include neuropeptides, plant stem cells, and Acyl-Glutathione, all designed to improve skin appearance and resilience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 27

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 20

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 12

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 16

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 24

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the S&P 500 E-Mini Futures Market Trends and Insights

Updated Category News Views 191

Market Overview: S&P 500 E-mini Futures The S&P 500 E-mini futures market is currently showcasing a tight trading range that remains close to its all-time highs. Both bulls and bears are vying for control, with bears needing additional selling pressure to maintain momentum. Understanding the Current Market Dynamics Analysis of the Weekly Chart This week, the E-mini...

Continue Reading
Exciting Developments Unveiled at ProXimo Conference 2025

Updated Category News Views 278

Exciting Developments Unveiled at ProXimo Conference 2025 San Diego - ProXimo at AVANCE Global, the premier gathering dedicated to enhancing Latino professional and economic mobility, has rolled out a series of programmatic updates. These include detailed sessions and a lineup of renowned speakers for its upcoming conference at the Manchester Grand Hyatt. Conference...

Continue Reading
Experience Unmatched Luxury with Exclusive 50% Off Offer

Updated Category News Views 152

The Shore Club Announces Exciting 50% Off Flash Sale 50 Minutes. 50% Off. One Chance to Save. PROVIDENCIALES, Turks and Caicos Islands — To celebrate its grand reopening, The Shore Club is introducing an unparalleled offer for visitors: The Big 5-0 Flash Sale. This exceptional sale will occur for 50 minutes only on Tuesday, October 14, from 12:00 – 12:50 PM EST. The...

Continue Reading
Lean Solutions Group Introduces New Ambassador Program for Growth

Updated Category News Views 218

Lean Solutions Group Launches the Lean Ambassador Program Lean Solutions Group (LSG) is excited to unveil its innovative ambassador program, designed specifically for professionals within the transportation and logistics space. This new initiative aims to incentivize Ambassadors through a referral program, allowing them to connect their networks to LSG's best-in-class...

Continue Reading
Supernus Pharmaceuticals Faces Downgrade Amid Prescription Concerns

Updated Category News Views 97

Recent Updates from Supernus Pharmaceuticals Piper Sandler has recently decided to downgrade Supernus Pharmaceuticals Inc (NASDAQ: SUPN). This decision is mainly due to growth in prescriptions for Qelbree, the company's leading ADHD medication, being slower than expected. The downgrade follows the unexpected lack of an increase in Qelbree prescriptions as students head...

Continue Reading